These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24086370)
1. Impact of glutathione-S-transferases (GST) polymorphisms and hypermethylation of relevant genes on risk of prostate cancer biochemical recurrence: a meta-analysis. Chen R; Ren S; Meng T; Aguilar J; Sun Y PLoS One; 2013; 8(9):e74775. PubMed ID: 24086370 [TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Rosenbaum E; Hoque MO; Cohen Y; Zahurak M; Eisenberger MA; Epstein JI; Partin AW; Sidransky D Clin Cancer Res; 2005 Dec; 11(23):8321-5. PubMed ID: 16322291 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in glutathione S-transferase genes increase risk of prostate cancer biochemical recurrence differentially by ethnicity and disease severity. Nock NL; Bock C; Neslund-Dudas C; Beebe-Dimmer J; Rundle A; Tang D; Jankowski M; Rybicki BA Cancer Causes Control; 2009 Dec; 20(10):1915-26. PubMed ID: 19568698 [TBL] [Abstract][Full Text] [Related]
4. Glutathione-S-transferase (GST) polymorphisms are associated with relapse after radical prostatectomy. Cotignola J; Leonardi DB; Shahabi A; Acuña AD; Stern MC; Navone N; Scorticati C; De Siervi A; Mazza O; Vazquez E Prostate Cancer Prostatic Dis; 2013 Mar; 16(1):28-34. PubMed ID: 23146971 [TBL] [Abstract][Full Text] [Related]
5. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy. Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338 [TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies. Gong M; Dong W; Shi Z; Xu Y; Ni W; An R PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206 [TBL] [Abstract][Full Text] [Related]
7. Association of genetic polymorphism of glutathione S-transferase (GSTM1, GSTT1, GSTP1) with bladder cancer susceptibility. Safarinejad MR; Safarinejad S; Shafiei N; Safarinejad S Urol Oncol; 2013 Oct; 31(7):1193-203. PubMed ID: 22154357 [TBL] [Abstract][Full Text] [Related]
8. Glutathione S-transferase gene polymorphisms (GSTM1, GSTT1, GSTP1) and prostate cancer: a case-control study in Tehran, Iran. Safarinejad MR; Shafiei N; Safarinejad SH Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):105-13. PubMed ID: 21243008 [TBL] [Abstract][Full Text] [Related]
9. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358 [TBL] [Abstract][Full Text] [Related]
10. GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis. Wang M; Li Y; Lin L; Song G; Deng T Mol Neurobiol; 2016 Mar; 53(2):1355-1364. PubMed ID: 25633095 [TBL] [Abstract][Full Text] [Related]
11. Polymorphisms at GSTM1 and GSTP1 gene loci and risk of prostate cancer in a South Indian population. Vijayalakshmi K; Vettriselvi V; Krishnan M; Shroff S; Vishwanathan KN; Jayanth VR; Paul SF Asian Pac J Cancer Prev; 2005; 6(3):309-14. PubMed ID: 16235991 [TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms of glutathione-S-transferase genes (GSTM1, GSTT1 and GSTP1) with familial prostate cancer risk in a Japanese population. Nakazato H; Suzuki K; Matsui H; Koike H; Okugi H; Ohtake N; Takei T; Nakata S; Hasumi M; Ito K; Kurokawa K; Yamanaka H Anticancer Res; 2003; 23(3C):2897-902. PubMed ID: 12926131 [TBL] [Abstract][Full Text] [Related]
13. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response. Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691 [TBL] [Abstract][Full Text] [Related]
14. Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors. Mavis CK; Morey Kinney SR; Foster BA; Karpf AR Prostate; 2009 Sep; 69(12):1312-24. PubMed ID: 19444856 [TBL] [Abstract][Full Text] [Related]
15. GSTP1 promoter methylation is associated with recurrence in early stage prostate cancer. Maldonado L; Brait M; Loyo M; Sullenberger L; Wang K; Peskoe SB; Rosenbaum E; Howard R; Toubaji A; Albadine R; Netto GJ; Hoque MO; Platz EA; Sidransky D J Urol; 2014 Nov; 192(5):1542-8. PubMed ID: 24769028 [TBL] [Abstract][Full Text] [Related]
16. Molecular margin status after radical prostatectomy using glutathione S-transferase P1 (GSTP1) promoter hypermethylation. Witt JH; Friedrich M; Jandrig B; Porsch M; Baumunk D; Liehr UB; Wendler JJ; Schostak M BJU Int; 2022 Oct; 130(4):454-462. PubMed ID: 34657365 [TBL] [Abstract][Full Text] [Related]
17. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387 [TBL] [Abstract][Full Text] [Related]
18. GSTM1 and GSTP1, but not GSTT1 genetic polymorphisms are associated with chronic myeloid leukemia risk and treatment response. Weich N; Ferri C; Moiraghi B; Bengió R; Giere I; Pavlovsky C; Larripa IB; Fundia AF Cancer Epidemiol; 2016 Oct; 44():16-21. PubMed ID: 27454607 [TBL] [Abstract][Full Text] [Related]
19. I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma. Jerónimo C; Varzim G; Henrique R; Oliveira J; Bento MJ; Silva C; Lopes C; Sidransky D Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):445-50. PubMed ID: 12010858 [TBL] [Abstract][Full Text] [Related]
20. Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. Richiardi L; Fiano V; Vizzini L; De Marco L; Delsedime L; Akre O; Tos AG; Merletti F J Clin Oncol; 2009 Jul; 27(19):3161-8. PubMed ID: 19470943 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]